Home        ΕΠΙΨΥ     


Greek  English 


The drug-related infectious diseases (DRID) indicator collects data on the prevalence of infectious diseases (HIV, HCV and HΒV) among injecting drug users (IDUs).

Data are collected yearly, mostly through diagnostic tests for HIV, HCV and HΒV infection performed on IDUs who contact treatment programmes in Greece. EKTEPN's reporting system consists of a nationwide network, bringing together (drug-free and substitution) treatment programmes, low-threshold agencies, public laboratories and reporting centres.

The network partners report individual data with the screening results for hepatitis B (based on the HBsAg, AntiHBc and AntiHBs markers), hepatitis C (anti-HCV (EIA) and Anti-HCV (RIBA), and HIV/AIDS (HIV1,2 Ab).

The individual data are reported to EKTEPN under an anonymous identification code to avoid double counting. The systematic collection of DRID data, on a yearly basis, makes it possible to monitor the prevalence of infectious diseases among IDUs over time and across Europe.

For more information about the implementation of the DRID indicator in Europe, click here.

DRIDI form. Click here to download the form developed by EKTEPN for submitting data about HIV, HCV, HΒV and other infections among IDUs (available in Greek)
Greece: prevalence of infectious diseases in IDUs. The latest available data are presented in the latest National Report of the Greek REITOX Focal Point on the State of Drugs in Greece which was submitted to EMCDDA in November 2010. Click here to download the relevant chapter.
Europe: prevalence of infectious diseases in IDUs. Click here to download the latest EMCDDA report, 2010 ANNUAL REPORT:The State of the Drugs Problem in Europe, with the latest available data.

Copyright ΕΚΤΕΠΝ © 2011 | Design: Alexandra Kokkevi